LivaNova PLC
LIVN
Rang in aandelen
#3813
LivaNova PLC is a global medical technology company dedicated to developing,... LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
Aandeelprijs
$78.25
Laatst gesynchroniseerd: 2026-10-21
Marktkapitalisatie
$4.30B
Verandering (1 dag)
-1.84%
Verandering (1 jaar)
42.65%
Land
GB
Handel LivaNova PLC (LIVN)
Categorie
Healthcare
Omzet van LivaNova PLC (LIVN)
Omzet in Jun 2026 TTM: $1.47B
Volgens de laatste financiële rapporten van LivaNova PLC bedraagt de huidige omzet van het bedrijf (TTM) $1.47B. In 2024 behaalde het bedrijf een omzet van $1.25B een stijging ten opzichte van de omzet in het jaar 2023, die $1.15B bedroeg. De omzet is het totale bedrag aan inkomsten dat een bedrijf genereert door de verkoop van goederen of diensten. In tegenstelling tot de winst worden er geen kosten afgetrokken.
Omzetgeschiedenis van LivaNova PLC van 2000 tot 2026
Omzet aan het einde van elk jaar
| Jaar | Omzet | Wijzigen |
|---|---|---|
| 2026 (TTM) | $1.47B | 6.01% |
| 2025 | $1.39B | 10.74% |
| 2024 | $1.25B | 8.66% |
| 2023 | $1.15B | 12.89% |
| 2022 | $1.02B | -1.31% |
| 2021 | $1.04B | 10.82% |
| 2020 | $934.24M | -13.83% |
| 2019 | $1.08B | -2.06% |
| 2018 | $1.11B | 9.35% |
| 2017 | $1.01B | -16.61% |
| 2016 | $1.21B | 316.35% |
| 2015 | $291.56M | 3.38% |
| 2014 | $282.01M | 10.89% |
| 2013 | $254.32M | 16.39% |
| 2012 | $218.50M | 14.72% |
| 2011 | $190.46M | 13.52% |
| 2010 | $167.78M | 16.83% |
| 2009 | $143.60M | 18.45% |
| 2008 | $121.23M | -7.44% |
| 2007 | $130.97M | 6.10% |
| 2006 | $123.44M | 19.33% |
| 2005 | $103.44M | -6.57% |
| 2004 | $110.72M | 5.99% |
| 2003 | $104.47M | 49.00% |
| 2002 | $70.11M | 46.40% |
| 2000 | $47.89M | 0.00% |
Omzet van vergelijkbare bedrijven of concurrenten
| Bedrijf | Omzet | Omzetverschil | Land |
|---|---|---|---|
| $46.59B | 3,065.79% |
US
|
|
| $35.48B | 2,311.40% |
IE
|
|
| $25.84B | 1,655.81% |
US
|
|
| $21.00B | 1,326.83% |
US
|
|
| - | - |
DE
|
